Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem Lett ; 21(16): 4913-8, 2011 Aug 15.
Article in English | MEDLINE | ID: mdl-21741835

ABSTRACT

The synthesis and biological evaluation of novel pyrazole and imidazole carboxamides as CB1 antagonists are described. As a part of eastern amide SAR, various chemically diverse motifs were introduced on rimonabant template. The central pyrazole core was also replaced with its conformationally constrained motif and imidazole moieties. In general, a range of modifications were well tolerated. Several molecules with low- and sub-nanomolar potencies were identified as potent CB1 receptor antagonists. The in vivo proof of principle for weight loss is demonstrated with a lead compound in DIO mice model.


Subject(s)
Aminoimidazole Carboxamide/pharmacology , Pyrazoles/pharmacology , Receptor, Cannabinoid, CB1/antagonists & inhibitors , Aminoimidazole Carboxamide/analogs & derivatives , Aminoimidazole Carboxamide/chemistry , Animals , Body Weight/drug effects , Dose-Response Relationship, Drug , Humans , Mice , Mice, Inbred C57BL , Molecular Structure , Pyrazoles/chemical synthesis , Pyrazoles/chemistry , Stereoisomerism , Structure-Activity Relationship
2.
J Chromatogr B Analyt Technol Biomed Life Sci ; 853(1-2): 88-96, 2007 Jun 15.
Article in English | MEDLINE | ID: mdl-17442643

ABSTRACT

Simultaneous separation and quantification of ezetimibe (EZM) and its phase-I metabolite i.e., ezetimibe ketone (EZM-K) and phase-II metabolite i.e., ezetimibe glucuronide (EZM-G) in various matrices was accomplished by gradient HPLC with UV detection. The assay procedure involved deproteinization of 500 microL of either incubation or bile sample containing analytes and internal standard (IS, theophylline) with 75 microL acetonitrile containing 25% perchloric acid. An aliquot of 100 microL supernatant was injected onto a C18 column. The chromatographic separation was achieved by gradient elution consisting of 0.05 M formic acid:acetonitrile:methanol:water at a flow rate of 1.0 mL/min. The detection of analyte peaks were achieved by monitoring the eluate using an UV detector set at 250 nm. Nominal retention times of IS, EZM-G, ezetimibe ketone glucuronide (EZM-KG), EZM and EZM-K were 9.39, 24.23, 27.82, 29.04 and 30.56 min, respectively. Average extraction efficiencies of EZM, EZM-G and IS was >75-80% and for EZM-K was >50% from all the matrices tested. Limit of quantitation (LOQ) for EZM, EZM-K and EZM-G was 0.02 microg/mL. Due to the lack of availability of reference standard of EZM-KG, the recovery and LOQ aspects for this metabolite were not assessed. Overall, the method is suitable for simultaneous measurement of EZM, and its phase-I and phase-II metabolite (EZM-G) in in vitro and in vivo studies.


Subject(s)
Azetidines/analysis , Bile/chemistry , Chromatography, High Pressure Liquid/methods , Spectrophotometry, Ultraviolet/methods , Animals , Azetidines/administration & dosage , Azetidines/chemistry , Azetidines/metabolism , Bile/metabolism , Ezetimibe , Glucuronides/analysis , Glucuronides/chemistry , Glucuronides/metabolism , Male , Molecular Structure , Rats , Rats, Wistar , Reproducibility of Results , Tandem Mass Spectrometry
SELECTION OF CITATIONS
SEARCH DETAIL
...